Amgen (NASDAQ:AMGN – Get Rating) was downgraded by equities researchers at Barclays from an “equal weight” rating to an “underweight” rating in a research report issued on Monday, MarketBeat Ratings reports. They currently have a $234.00 target price on the medical research company’s stock. Barclays‘s price target indicates a potential downside of 13.99% from the […]
Sawgrass Asset Management LLC purchased a new stake in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 77,946 shares of the medical research company’s stock, valued at approximately $18,849,000. Amgen comprises approximately 2.0% of […]
Amgen (NASDAQ:AMGN – Get Rating) had its target price increased by Oppenheimer from $285.00 to $290.00 in a research note issued to investors on Wednesday morning, The Fly reports. Other equities analysts also recently issued research reports about the stock. StockNews.com upgraded shares of Amgen from a buy rating to a strong-buy rating in a […]
Amgen (NASDAQ:AMGN – Get Rating) had its price objective raised by research analysts at Oppenheimer from $285.00 to $290.00 in a research note issued to investors on Wednesday, The Fly reports. Oppenheimer’s price objective would indicate a potential upside of 12.95% from the company’s current price. Other research analysts have also recently issued research reports […]
Analysts expect Laboratory Co. of America Holdings (NYSE:LH – Get Rating) to report $3.84 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Laboratory Co. of America’s earnings, with estimates ranging from $3.74 billion to $4.02 billion. Laboratory Co. of America also posted sales of […]